Potential role of lipids in the progression of diabetic nephropathy

Clinical Nephrology

Volumn 46, Issue 4, 1996, Pages 262-265

  Kramer Guth A ^a   Quaschning, T ^b   Gheiber, S ^a   Wanner, C ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cholesterol; Diabetic nephropathy; Glomerulosclerosis; Modified LDL; Triglycerides

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECEPTOR; SCAVENGER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; DYSLIPOPROTEINEMIA; FOAM CELL; GLOMERULOSCLEROSIS; HUMAN; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PATHOGENESIS; PROTEINURIA; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; RISK FACTORS;

EID: 0029847761     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H 1994 Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91: 9441-9445
2. Diamond JR, Karnovsky MJ 1988 Focal and segmental glomerulosclerosis: analogies to atherosclerosis [Review]. Kidney Int 33: 917-924
3. Gröne HJ, Walli AK, Gröne E, Krämer A, Clemens MR, Seidel D 1980 Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 37: 1449-1459
4. Gupta S, Rifici V, Crowley S, Brownlee M, Shan Z, Schlondorff D 1992 Interactions of LDL and modified LDL with mesangial cells and matrix. Kidney Int 41: 1161-1169
5. Howard BV 1987 Lipoprotein metabolism in diabetes mellitus [Review]. J Lipid Res 28: 613-628
6. Jerums G, Allen TJ, Tsalamandris C, Akdenis A, Shinka A, Gilbert R, Cooper ME 1993 Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non insulin-dependent) and type 1 (insulin-dependent) diabetic patients. Diabetologia 36: 1037-1044
7. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP 1991 Hyperlipidemia and progressive renal disease [Review]. Kidney Int Suppl 31: S41-S48
8. Keane WF, Shapiro BE 1990 Renal protective effects of angiotensin-converting enzyme inhibition [Review]. Am J Cardiol 65: 491-531
9. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF 1991 Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138: 413-420
10. Krauss RM 1992 Low density lipoprotein subclasses and risk of coronary heart disease. Curr Opin Lipidol 2: 248-252
11. Krämer A, Nauck M, Pavenstädt H, Schwedler S, Wieland H, Schollmeyer P, Wanner C 1993 Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells. Kidney Int 44: 1341-1351
12. Krämer-Guth A, Greiber S, Pavenstädt H, Quaschning T, Winkler K, Schollmeyer P, Wanner C 1996 Interaction of oxidized lipoprotein(a) with human mesangial cells and matrix. Kidney Int 49: 1250-1261
13. Lee HS, Koh HI 1994 Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells. Lab Invest 71: 200-208
14. Lam KSL, Cheng IKP, Janus ED, Pang RWC 1995 Cholesterol-lowering therapy may retard the progression of diabetic nephropathy Diabetologia 38: 604-609
15. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA 1982 Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22: 430-436
16. Lyons TJ 1993 Glycation and oxidation: a role in the pathogenesis of atherosclerosis [Review]. Am J Cardiol 71: 26B-31B
17. Moorhead JF, Chan MK, El Nahas M, Varghese Z 1982 Lipid nephrotoxicity in chronic progressive glomerular and tubulo-intestinal disease. Lancet 1: 1309-1311 (Abstract)
18. Mulec H, Johnson SA, Björk S 1990 Relation between serum cholesterol and diabetic nephropathy. Lancet 335: 1537-1538
19. Mulec H, Johnson SA, Wiklund O, Bjorck S 1993 Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22: 196-201
20. Panzram G 1983 Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-131
21. Ravid M, Neumann L, Lishner M 1995 Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors. Kidney Int 47: 907-910
22. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman P-O 1993 Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 63: 279-285
23. Schlondorff D 1993 Cellular mechanisms of lipid injury in the glomerulus [Review]. Am J Kidney Dis 22: 72-82
24. Stewart MW, Laker MF, Alberti KGMM 1994 The distribution of lipids to coronary heart disease in diabetes mellitus. J Int Med 236: 41-46
25. Taskinen MR 1992 Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus [Review]. Diabetes 41 (Suppl 2): 12-17
26. Wardle EN 1992 Cellular biology of glomerulosclerosis. Nephron 61: 125-128
27. Wells-Knecht MC, Huggins TH, Dyer DG, Thorpe SR, Baynes JW 1993 Oxidized amino acids in lens protein with age. Measurement of 0-tyrosine and dityrosine in the aging human lens. J Biol Chem 268: 12348-12352